Holen Sie sich die Stockscreener-App
41.40
3.70%
-1.59
Handel nachbörslich:
41.40
Schlusskurs vom Vortag:
$42.99
Offen:
$42.26
24-Stunden-Volumen:
390.68K
Relative Volume:
0.66
Marktkapitalisierung:
$1.28B
Einnahmen:
$1.32B
Nettoeinkommen (Verlust:
$110.20M
KGV:
11.69
EPS:
3.5417
Netto-Cashflow:
$148.24M
1W Leistung:
-9.74%
1M Leistung:
+1.82%
6M Leistung:
-24.69%
1J Leistung:
-28.13%
1-Tages-Spanne:
$41.24
$42.41
1-Wochen-Bereich:
$41.24
$46.55
52-Wochen-Spanne:
$35.37
$64.87
Conmed Corp Stock (CNMD) Company Profile
Firmenname
Conmed Corp
Sektor
Branche
Telefon
727-214-2974
Adresse
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
41.40 | 1.33B | 1.32B | 110.20M | 148.24M | 3.5417 |
|
ABT
Abbott Laboratories
|
111.04 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
370.50 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
93.01 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.99 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.89 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-12 | Herabstufung | Needham | Buy → Hold |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-01 | Bestätigt | Needham | Buy |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2023-03-27 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-10-06 | Hochstufung | Needham | Hold → Buy |
| 2021-07-15 | Eingeleitet | UBS | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2019-11-26 | Herabstufung | Needham | Buy → Hold |
| 2019-11-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-31 | Bestätigt | Needham | Buy |
| 2019-10-04 | Bestätigt | Needham | Buy |
| 2019-08-22 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | Eingeleitet | Stifel | Buy |
| 2019-04-16 | Bestätigt | Needham | Buy |
| 2019-01-23 | Bestätigt | Needham | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-07 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-02-01 | Bestätigt | Needham | Buy |
| 2017-07-27 | Bestätigt | Needham | Buy |
| 2017-04-27 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | Bestätigt | Needham | Buy |
| 2016-11-18 | Bestätigt | Needham | Buy |
| 2016-07-28 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | Bestätigt | Needham | Buy |
| 2015-10-22 | Bestätigt | Northland Capital | Market Perform |
Alle ansehen
Conmed Corp Aktie (CNMD) Neueste Nachrichten
The Technical Signals Behind (CNMD) That Institutions Follow - Stock Traders Daily
Equity awards for CONMED (CNMD) VP Matthew Schabacker detailed in Form 4 - Stock Titan
CONMED Corp (NYSE: CNMD) treasurer awarded 5,896 RSUs - Stock Titan
CONMED (NYSE: CNMD) grants RSUs and stock options to EVP - Stock Titan
CONMED (NYSE: CNMD) EVP granted RSUs and stock options in 2026 award - Stock Titan
Equity awards granted to CONMED (CNMD) General Counsel Hollie Foust - Stock Titan
Equity grant: CONMED (CNMD) VP Corporate Controller receives 5,896 RSUs - Stock Titan
CONMED Earnings Reset Story After Strong Quarter And Higher Guidance - Yahoo Finance
CNMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Assessing CONMED (CNMD) Valuation After Mixed Short And Long Term Share Price Performance - simplywall.st
Director Mark Kaye converts 152 RSUs at CONMED (NYSE: CNMD) into stock - Stock Titan
Momentum Shift: Does CONMED Corporation have declining or rising EPSMarket Activity Report & Precise Swing Trade Alerts - baoquankhu1.vn
3 Reasons CNMD is Risky and 1 Stock to Buy Instead - Finviz
Villanova Investment Management Co LLC Acquires New Shares in CONMED Corporation $CNMD - MarketBeat
Precision Trading with Conmed Corp.Ordinary Shares (CNMD) Risk Zones - Stock Traders Daily
CONMED (NYSE:CNMD) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Envestnet Asset Management Inc. Boosts Holdings in CONMED Corporation $CNMD - Defense World
Decoding Conmed Corp (CNMD): A Strategic SWOT Insight - GuruFocus
CONMED Corp SEC 10-K Report - TradingView
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - Finviz
CONMED (NYSE:CNMD) Upgraded at Zacks Research - Defense World
A Look At CONMED (CNMD) Valuation After Earnings And Growth In Key Surgical Segments - simplywall.st
CONMED (NYSE:CNMD) Upgraded to Hold at Zacks Research - MarketBeat
5 Must-Read Analyst Questions From CONMED's Q4 Earnings Call - Finviz
5 Essential Analyst Inquiries from CONMED’s Fourth Quarter Earnings Discussion - Bitget
Earnings call transcript: CONMED Q4 2025 beats EPS forecasts, stock dips - Investing.com
Assessing CONMED (CNMD) Valuation After Q4 Results And Surgical Portfolio Shift - Yahoo Finance UK
Street Watch: Should I trade or invest in Taboolacom Ltd Equity Warrant2025 Pullback Review & Long-Term Growth Portfolio Plans - baoquankhu1.vn
CONMED Q4 Earnings Call Highlights - Defense World
Conmed Corporation stock hits 52-week low at 38.05 USD By Investing.com - Investing.com Nigeria
CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up - Yahoo Finance
Conmed Corporation stock hits 52-week low at 38.05 USD - Investing.com
CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook - Finviz
CONMED Corporation (NYSE:CNMD) Q4 2025 Earnings Call Transcript - Insider Monkey
What Analysts Are Saying About Conmed Stock - Benzinga
Conmed Corp (CNMD) Q4 2025 Earnings Call Highlights: Strong Orthopedic Sales Drive Growth ... - Yahoo Finance
CONMED Corp shares slip after Q4 earnings beat, cautious guidance - AlphaStreet News -
Compared to Estimates, Conmed (CNMD) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
CONMED Q4 2025 presentation slides: Strong international growth drives earnings beat - Investing.com
CONMED (CNMD) Q4 2025 Earnings Call Transcript - AOL.com
CONMED Q4 Adjusted Earnings, Revenue Rise; 2026 Guidance Set - marketscreener.com
Earnings call transcript: CONMED beats Q4 2025 estimates, stock dips - Investing.com
Conmed: Q4 Earnings Snapshot - kare11.com
(CNMD) CONMED Expects 2026 Revenue Range $1.35B-$1.38B, vs. FactSet Est of $1.38B - marketscreener.com
(CNMD) CONMED Expects 2026 Adjusted Earnings Range $4.30-$4.45, vs. FactSet Est of $4.50 - marketscreener.com
CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars - Finviz
Conmed: Fourth Quarter Financial Highlights - Bitget
Conmed Corp. Profit Retreats In Q4 - Nasdaq
Earnings Flash (CNMD) CONMED Corporation Reports Q4 Revenue $373.2M, vs. FactSet Est of $366.9M - marketscreener.com
Is There Now An Opportunity In CONMED (CNMD) After Prolonged Share Price Weakness - Yahoo Finance
Finanzdaten der Conmed Corp-Aktie (CNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):